Predictors of loss of hepatitis B surface antigen in HIV-infected patients

作者: George Psevdos Jr

DOI: 10.3748/WJG.V16.I9.1093

关键词:

摘要: AIM: To study factors associated with loss of hepatitis B surface antigen (HBsAg) in patients co-infected human immunodeficiency virus (HIV) and (HBV). METHODS: We retrospectively reviewed the medical records 5681 followed up at two New York City HIV clinics from January 1999 to May 2007. Clinical laboratory parameters including baseline follow-up viral loads, CD4 cell counts, alanine transaminase levels, demographics, presence C infection, treatment highly active antiretroviral therapy dually against both HBV were analyzed determine HBsAg. RESULTS: Three hundred fifty five (355/5681, 6.84%) evaluated. Of these, 226 more than 12 mo included further analysis HBsAg long-term follow-up. In univariate analysis, count was (P = 0.052). Cox regression revealed that > 500 cells/mm3 0.016, odds ratio: 76.174, 95% confidence interval: 2.233-2598.481). CONCLUSION: Our showed an interesting association HIV-HBV higher count, suggesting T-cell cytolytic activity may still be effective clearing infection.

参考文章(15)
Norbert Bräu, Rena K Fox, Peiying Xiao, Kristen Marks, Zeenat Naqvi, Lynn E Taylor, Anita Trikha, Morris Sherman, Mark S Sulkowski, Douglas T Dieterich, Michael O Rigsby, Teresa L Wright, Maria D Hernandez, Mamta K Jain, Gajendra K Khatri, Richard K Sterling, Maurizio Bonacini, Catherine A Martyn, Ayse Aytaman, Josep M Llovet, Sheldon T Brown, Edmund J Bini, North American Liver Cancer in HIV Study Group, None, Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. Journal of Hepatology. ,vol. 47, pp. 527- 537 ,(2007) , 10.1016/J.JHEP.2007.06.010
George K.K. Lau, Teerha Piratvisuth, Kang Xian Luo, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael W. Fried, Wan Cheng Chow, Seung Woon Paik, Wen Yu Chang, Thomas Berg, Robert Flisiak, Philip McCloud, Nigel Pluck, Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B The New England Journal of Medicine. ,vol. 352, pp. 2682- 2695 ,(2005) , 10.1056/NEJMOA043470
José Antonio Carton, José Antonio Maradona, Victor Asensi, Manuel Rodríguez, Ana Martínez, Lamivudine for chronic hepatitis B and HIV co-infection. AIDS. ,vol. 13, pp. 1002- 1003 ,(1999) , 10.1097/00002030-199905280-00024
Anna SF Lok, Brian J McMahon, None, Chronic hepatitis B: Update 2009 Hepatology. ,vol. 50, pp. 661- 662 ,(2009) , 10.1002/HEP.23190
Spyros A. Kalams, Bruce D. Walker, The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses Journal of Experimental Medicine. ,vol. 188, pp. 2199- 2204 ,(1998) , 10.1084/JEM.188.12.2199
Miriam J. Alter, Epidemiology of viral hepatitis and HIV co-infection Journal of Hepatology. ,vol. 44, pp. S6- S9 ,(2006) , 10.1016/J.JHEP.2005.11.004
Massimo Puoti, Carlo Torti, Raffaele Bruno, Gaetano Filice, Giampiero Carosi, None, Natural history of chronic hepatitis B in co-infected patients Journal of Hepatology. ,vol. 44, pp. S65- S70 ,(2006) , 10.1016/J.JHEP.2005.11.015
J. Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, Alex J. V. Thompson, Peter Revill, David Iser, John Slavin, Supranee Buranapraditkun, Pip Marks, Gail Matthews, David A. Cooper, Stephen J. Kent, Paul U. Cameron, Joe Sasadeusz, Paul Desmond, Stephen Locarnini, Gregory J. Dore, Kiat Ruxrungtham, Sharon R. Lewin, Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. Journal of Virology. ,vol. 83, pp. 7649- 7658 ,(2009) , 10.1128/JVI.00183-09
J. Judy Chang, Fiona Wightman, Angeline Bartholomeusz, Anna Ayres, Stephen J. Kent, Joseph Sasadeusz, Sharon R. Lewin, Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy Journal of Virology. ,vol. 79, pp. 3038- 3051 ,(2005) , 10.1128/JVI.79.5.3038-3051.2005